News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
230,444 Results
Type
Article (14212)
Company Profile (25)
Press Release (216206)
Multimedia
Podcasts (8)
Webinars (1)
Section
Business (72522)
Career Advice (556)
Deals (12606)
Drug Delivery (21)
Drug Development (27137)
Employer Resources (14)
FDA (5220)
Job Trends (4912)
News (118009)
Policy (9094)
Tag
Academia (556)
Accelerated approval (3)
Allergies (40)
Alliances (11452)
ALS (35)
Alzheimer's disease (422)
Antibody-drug conjugate (ADC) (49)
Approvals (5347)
Artificial intelligence (55)
Autoimmune disease (14)
Automation (4)
Bankruptcy (94)
Best Places to Work (3725)
BIOSECURE Act (3)
Biosimilars (52)
Biotechnology (21)
Bladder cancer (42)
Brain cancer (16)
Breast cancer (167)
Cancer (1171)
Cardiovascular disease (100)
Career advice (415)
Career pathing (4)
CAR-T (52)
CDC (6)
Cell therapy (156)
Cervical cancer (11)
Clinical research (24066)
Collaboration (226)
Compensation (210)
Complete response letters (5)
COVID-19 (701)
CRISPR (18)
C-suite (79)
Cystic fibrosis (28)
Data (1642)
Depression (38)
Diabetes (147)
Diagnostics (1727)
Digital health (11)
Diversity, equity & inclusion (6)
Drug discovery (30)
Drug pricing (30)
Drug shortages (2)
Duchenne muscular dystrophy (63)
Earnings (50107)
Editorial (10)
Employer branding (4)
Employer resources (13)
Events (35343)
Executive appointments (121)
FDA (6030)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (220)
Gene editing (35)
Generative AI (5)
Gene therapy (109)
GLP-1 (282)
Government (1031)
Grass and pollen (4)
Guidances (292)
Healthcare (5297)
HIV (12)
Huntington's disease (8)
IgA nephropathy (16)
Immunology and inflammation (65)
Immuno-oncology (4)
Indications (19)
Infectious disease (752)
Inflammatory bowel disease (48)
Inflation Reduction Act (2)
Influenza (23)
Intellectual property (35)
Interviews (90)
IPO (7108)
IRA (7)
Job creations (1386)
Job search strategy (391)
Kidney cancer (9)
Labor market (20)
Layoffs (134)
Leadership (1)
Legal (2186)
Liver cancer (22)
Longevity (2)
Lung cancer (220)
Lymphoma (83)
Machine learning (4)
Management (1)
Manufacturing (104)
MASH (48)
Medical device (3765)
Medtech (3770)
Mergers & acquisitions (5757)
Metabolic disorders (328)
Multiple sclerosis (46)
NASH (6)
Neurodegenerative disease (46)
Neuropsychiatric disorders (28)
Neuroscience (697)
NextGen: Class of 2025 (1338)
Non-profit (951)
Now hiring (5)
Obesity (134)
Opinion (51)
Ovarian cancer (36)
Pain (46)
Pancreatic cancer (52)
Parkinson's disease (54)
Patents (60)
Patient recruitment (64)
Peanut (15)
People (11354)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (6288)
Phase II (10049)
Phase III (9073)
Pipeline (1547)
Policy (26)
Postmarket research (992)
Preclinical (2185)
Press Release (12)
Prostate cancer (77)
Psychedelics (8)
Radiopharmaceuticals (90)
Rare diseases (151)
Real estate (1415)
Recruiting (5)
Regulatory (6736)
Reports (19)
Research institute (500)
Resumes & cover letters (94)
Rett syndrome (5)
RNA editing (1)
RSV (17)
Schizophrenia (53)
Series A (34)
Series B (23)
Sickle cell disease (21)
Special edition (9)
Spinal muscular atrophy (43)
Sponsored (7)
Startups (807)
Stomach cancer (2)
Supply chain (14)
Tariffs (15)
The Weekly (8)
Vaccines (226)
Venture capital (20)
Weight loss (100)
Women's health (11)
Worklife (3)
Date
Today (1)
Last 7 days (200)
Last 30 days (580)
Last 365 days (9713)
2025 (7546)
2024 (10902)
2023 (12392)
2022 (15248)
2021 (16750)
2020 (15561)
2019 (11763)
2018 (8826)
2017 (8376)
2016 (7141)
2015 (9009)
2014 (27504)
2013 (35250)
2012 (5392)
2011 (5752)
2010 (5166)
Location
Africa (224)
Alabama (17)
Arizona (63)
Arkansas (5)
Asia (14051)
Australia (2192)
California (2663)
Canada (797)
China (286)
Colorado (120)
Connecticut (131)
Delaware (89)
Europe (34203)
Florida (362)
Georgia (92)
Idaho (13)
Illinois (181)
India (15)
Indiana (173)
Iowa (1)
Japan (120)
Kansas (30)
Kentucky (9)
Louisiana (7)
Maine (29)
Maryland (352)
Massachusetts (1900)
Michigan (94)
Minnesota (150)
Mississippi (2)
Missouri (19)
Montana (8)
Nebraska (1)
Nevada (35)
New Hampshire (27)
New Jersey (910)
New Mexico (1)
New York (848)
North Carolina (322)
Northern California (1310)
Ohio (56)
Oklahoma (5)
Oregon (5)
Pennsylvania (592)
Puerto Rico (2)
Rhode Island (5)
South America (366)
South Carolina (7)
Southern California (1045)
Tennessee (37)
Texas (372)
United States (9738)
Utah (82)
Virginia (37)
Washington D.C. (14)
Washington State (189)
West Virginia (2)
Wisconsin (14)
230,444 Results for "14".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Affinia Therapeutics to Participate in Upcoming Investor Conferences - October 14, 2025
October 15, 2025
·
1 min read
Press Releases
Scryb Closes Oversubscribed Private Placement for over $1.4M
September 29, 2025
·
5 min read
Press Releases
Personalized Cancer Vaccine Market Size to Exceed USD 8,501.14 Million by 2034
October 15, 2025
·
1 min read
Press Releases
Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium
October 13, 2025
·
6 min read
Press Releases
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
September 16, 2025
·
12 min read
Press Releases
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
September 16, 2025
·
12 min read
Press Releases
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
September 22, 2025
·
4 min read
Mergers & acquisitions
Novartis Deals in Cardio Again, Dropping $1.4B To Acquire Tourmaline
Novartis has been investing heavily in its cardiovascular pipeline this year, forging partnerships with Flagship startup ProFound Therapeutics and China’s Argo Biopharmaceutical, among others.
September 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
September 15, 2025
·
5 min read
Press Releases
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
September 29, 2025
·
1 min read
1 of 23,045
Next
